Though currently only FDA-approved for type 2 diabetes and obesity, people who have type 1 diabetes may want to take GLP-1 ...
Jardiance, Farxiga, and other SGLT-2 inhibitors have demonstrated many benefits in addition to improving A1C: namely, slowing kidney disease and protecting against heart failure. The latest data from ...
According to a recent update by the FDA, shortages for Lilly’s Mounjaro and Zepbound will persist through at least June 2024. New diabetes and weight loss medications like Ozempic, Wegovy, Mounjaro, ...
People with type 1 diabetes who take a GLP-1 drug for weight loss or other health benefits may see unexpected low blood sugar levels, as well as a higher risk of diabetic ketoacidosis. While GLP-1 ...
What is the trial researching? This study is investigating how a new type of diabetes education program affects glycemic control and quality of life. This study specifically focuses on people with ...
According to a recent update by the FDA, shortages for Lilly’s Mounjaro and Zepbound will persist through at least June 2024. New diabetes and weight loss medications like Ozempic, Wegovy, Mounjaro, ...
Charcot foot is an uncommon, but serious diabetes complication. One of the best ways to prevent it is with simple routine foot care, such as wearing well-fitting shoes and keeping feet clean. Charcot ...
You notice there’s a buzz around “HIIT” workouts. Your gym is offering classes and you see it suggested online. But what is it? Is it safe for someone with diabetes? Tired of the treadmill or bike?
New data from a large clinical trial of adults who had experienced a recent heart attack showed that the SGLT-2 inhibitor Jardiance reduced the risk of ...
A new TikTok trend touts that "Oatzempic" – a combo of oats, water, and lime juice – encourages rapid weight loss. But experts warn the concoction has little benefit,... The U.S. News & World Report ...
Charcot foot is an uncommon, but serious diabetes complication. One of the best ways to prevent it is with simple routine foot care, such as wearing well-fitting shoes... Explore GLP-1 agonists for ...
Independent data monitoring committee found the deaths were unrelated to VX-880 investigational treatment; new participants can now enroll again.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results